Literature DB >> 17207473

Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia.

Kuei-Yuan Tseng1, Barbara L Lewis, Barbara K Lipska, Patricio O'Donnell.   

Abstract

BACKGROUND: A neonatal ventral hippocampal lesion (NVHL) induces behavioral and physiological anomalies mimicking pathophysiological changes of schizophrenia. Because prefrontal cortical (PFC) pyramidal neurons recorded from adult NVHL rats exhibit abnormal responses to activation of the mesocortical dopaminergic (DA) system, we explored whether these changes are due to an altered DA modulation of pyramidal neurons.
METHODS: Whole-cell recordings were used to examine the effects of DA and glutamate agonists on cell excitability in brain slices obtained from pre- (postnatal day [PD] 28-35) and post-pubertal (PD > 61) sham and NVHL animals.
RESULTS: N-methyl d-aspartate (NMDA), alpha-amino-3-hydroxy-5-methylisoxazole propionate (AMPA), and the D(1) agonist SKF38393 increased excitability of deep layer pyramidal neurons in a concentration-dependent manner. The opposite effect was observed with the D(2) agonist quinpirole. The effects of NMDA (but not AMPA) and SKF38393 on cell excitability were significantly higher in slices from NVHL animals, whereas quinpirole decrease of cell excitability was reduced. These differences were not observed in slices from pre-pubertal rats, suggesting that PFC DA and glutamatergic systems become altered after puberty in NVHL rats.
CONCLUSIONS: A disruption of PFC dopamine-glutamate interactions might emerge after puberty in brains with an early postnatal deficit in hippocampal inputs, and this disruption could contribute to the manifestation of schizophrenia-like symptoms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17207473      PMCID: PMC2204086          DOI: 10.1016/j.biopsych.2006.10.012

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  42 in total

1.  Prefrontal lesion reverses abnormal mesoaccumbens response in an animal model of schizophrenia.

Authors:  Yukiori Goto; Patricio O'Donnell
Journal:  Biol Psychiatry       Date:  2004-01-15       Impact factor: 13.382

2.  Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons.

Authors:  D J Surmeier; J Bargas; H C Hemmings; A C Nairn; P Greengard
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

3.  Prefrontal cortical and hippocampal modulation of dopamine-mediated effects.

Authors:  B K Lipska; D R Weinberger
Journal:  Adv Pharmacol       Date:  1998

4.  Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia.

Authors:  G Le Pen; A J Grottick; G A Higgins; J R Martin; F Jenck; J L Moreau
Journal:  Behav Pharmacol       Date:  2000-06       Impact factor: 2.293

5.  D(1) dopamine receptors potentiate nmda-mediated excitability increase in layer V prefrontal cortical pyramidal neurons.

Authors:  J Wang; P O'Donnell
Journal:  Cereb Cortex       Date:  2001-05       Impact factor: 5.357

6.  De-coupling of cognitive performance and cerebral functional response during working memory in schizophrenia.

Authors:  Garry D Honey; Edward T Bullmore; Tonmoy Sharma
Journal:  Schizophr Res       Date:  2002-01-01       Impact factor: 4.939

7.  Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia.

Authors:  R A Chambers; J Moore; J P McEvoy; E D Levin
Journal:  Neuropsychopharmacology       Date:  1996-12       Impact factor: 7.853

8.  Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia.

Authors:  B K Lipska; G E Jaskiw; D R Weinberger
Journal:  Neuropsychopharmacology       Date:  1993-08       Impact factor: 7.853

9.  Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms.

Authors:  Kuei Y Tseng; Patricio O'Donnell
Journal:  J Neurosci       Date:  2004-06-02       Impact factor: 6.167

10.  Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage.

Authors:  B K Lipska; D R Weinberger
Journal:  Neuropsychopharmacology       Date:  1994-05       Impact factor: 7.853

View more
  50 in total

1.  Concurrent upregulation of postsynaptic L-type Ca(2+) channel function and protein kinase A signaling is required for the periadolescent facilitation of Ca(2+) plateau potentials and dopamine D1 receptor modulation in the prefrontal cortex.

Authors:  Li-Jun Heng; Julie A Markham; Xiu-Ti Hu; Kuei Y Tseng
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

2.  Transient inactivation of the neonatal ventral hippocampus permanently disrupts the mesolimbic regulation of prefrontal cholinergic transmission: implications for schizophrenia.

Authors:  Julie M Brooks; Martin Sarter; John P Bruno
Journal:  Neuropsychopharmacology       Date:  2011-08-03       Impact factor: 7.853

3.  Genetic modulation of GABA levels in the anterior cingulate cortex by GAD1 and COMT.

Authors:  Stefano Marenco; Antonina A Savostyanova; Jan Willem van der Veen; Matthew Geramita; Alexa Stern; Alan S Barnett; Bhaskar Kolachana; Eugenia Radulescu; Fengyu Zhang; Joseph H Callicott; Richard E Straub; Jun Shen; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2010-03-31       Impact factor: 7.853

4.  Altered basolateral amygdala encoding in an animal model of schizophrenia.

Authors:  Alex Hernandez; Amanda C Burton; Patricio O'Donnell; Geoffrey Schoenbaum; Matthew R Roesch
Journal:  J Neurosci       Date:  2015-04-22       Impact factor: 6.167

5.  Differences between adolescents and adults in the acute effects of PCP and ketamine and in sensitization following intermittent administration.

Authors:  Angelica Rocha; Nigel Hart; Keith A Trujillo
Journal:  Pharmacol Biochem Behav       Date:  2017-04-22       Impact factor: 3.533

6.  Late adolescent expression of GluN2B transmission in the prefrontal cortex is input-specific and requires postsynaptic protein kinase A and D1 dopamine receptor signaling.

Authors:  Eden Flores-Barrera; Daniel R Thomases; Li-Jun Heng; Daryn K Cass; Adriana Caballero; Kuei Y Tseng
Journal:  Biol Psychiatry       Date:  2013-09-13       Impact factor: 13.382

7.  An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia.

Authors:  Li Chen; Stephanie M Perez; Daniel J Lodge
Journal:  Dev Neurobiol       Date:  2014-03-03       Impact factor: 3.964

Review 8.  The role of oscillations and synchrony in cortical networks and their putative relevance for the pathophysiology of schizophrenia.

Authors:  Peter J Uhlhaas; Corinna Haenschel; Danko Nikolić; Wolf Singer
Journal:  Schizophr Bull       Date:  2008-06-17       Impact factor: 9.306

9.  Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia.

Authors:  Alessandro Bertolino; Leonardo Fazio; Grazia Caforio; Giuseppe Blasi; Antonio Rampino; Raffaella Romano; Annabella Di Giorgio; Paolo Taurisano; Audrey Papp; Julia Pinsonneault; Danxin Wang; Marcello Nardini; Teresa Popolizio; Wolfgang Sadee
Journal:  Brain       Date:  2008-10-01       Impact factor: 13.501

10.  Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment.

Authors:  Kathleen S Alexander; Julie M Brooks; Martin Sarter; John P Bruno
Journal:  Neuropsychopharmacology       Date:  2009-08-19       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.